US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist
  • 99.880
  • +1.710+1.74%
Trading Jan 23 15:17 ET
199.69BMarket Cap11.72P/E (TTM)

Novartis AG Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Novartis AG Q4 2024 Estimates Date

Currency：USDJan 31, 2025

Estimate YoY
Revenue
12.77B
+11.75%
EPS
1.04
-74.84%
Analyst Rating
Buy

Dec 31, 2024

Novartis AG Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.559B--
Jan 31, 20252024/Q4-- / 12.765B--
Oct 29, 20242024/Q312.823B / 12.666B--
Jul 18, 20242024/Q212.512B / 12.319B--
Apr 23, 20242024/Q111.829B / 11.498B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.559B--
Jan 31, 20252024/Q4-- / 12.765B--
Oct 29, 20242024/Q312.823B / 12.666B--
Jul 18, 20242024/Q212.512B / 12.319B--
Apr 23, 20242024/Q111.829B / 11.498B--

Unlock Free Earnings Estimates

Novartis AG Earnings Reports

  • 6-K: Novartis Upgrades Mid-Term Guidance

    Nov 25, 2024 10:22 ET

  • 6-K: Financial Report Q3 2024

    Oct 29, 2024 06:23 ET

  • 6-K: Explanatory Note

    Sep 18, 2024 16:42 ET

  • 6-K: Novartis Second Quarter and Half Year 2024 Condensed Interim Financial Report – Supplementary Data

    Jul 18, 2024 06:11 ET

    • Read more

    Trending Stocks
    Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

    Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

    Symbol Mini Chart % Chg
    Ecopetrol
    EC
    +1.69%
    Meta Platforms
    META
    +1.35%
    Oracle
    ORCL
    +0.80%
    Salesforce
    CRM
    +0.71%
    MicroStrategy
    MSTR
    +0.28%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      33.33%

    • Hold

      66.67%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Cancer Research
    Cancer Research
    Intraday+1.37%
    CAR-T Therapy
    CAR-T Therapy
    Intraday+1.08%